[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100652779":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":29,"centralContacts":33,"locations":42,"responsibleParty":58,"collaborators":60,"id":64,"slug":65,"hasResults":66,"nctId":67,"briefTitle":68,"officialTitle":69,"acronym":70,"eligibilityCriteria":71,"healthyVolunteers":66,"sex":72,"minAge":73,"maxAge":11,"enrollmentInfo":74,"targetDuration":11,"studyType":77,"phases":78,"briefSummary":80,"conditions":81,"keywords":85,"overallStatus":44,"whyStopped":11,"lastUpdateSubmitDate":88,"lastUpdatePostDateStruct":89,"startDateStruct":92,"completionDateStruct":94,"leadSponsor":96,"locationsCount":97},{"fullName":5,"class":6},"Rhode Island Hospital","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"Vira Path","EXPERIMENTAL",null,[13,14],"Behavioral: Vira Platform","Behavioral: Treatment-As-Usual",{"label":16,"type":17,"description":11,"interventionNames":18},"Treatment-as-Usual","ACTIVE_COMPARATOR",[14],[20,25],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":11},"BEHAVIORAL","Vira Platform","The Vira Platform is a digitally enhanced mental health care platform consisting of a patient smartphone application that utilizes mobile sensing to garner insight about patterns of behavior related to negative affect, sleep, and anhedonia while simultaneously providing just-in-time nudges to increase positive interactions with the environment. Behavioral activation is the primary intervention being deployed through the Vira App. It is accompanied by a practitioner platform that is delivered through certified peer recovery support specialist to encourage engagement with the app and promote social support.",[9],{"type":21,"name":26,"description":27,"armGroupLabels":28,"otherNames":11},"Treatment-As-Usual","The treatment-as-usual condition consists of standard outpatient buprenorphine or methadone treatment. These medications are among those considered to be the gold standard of care for treating opioid use disorder, and therefore, represents an adequate control intervention for this study.",[16,9],[30],{"name":31,"affiliation":5,"role":32},"Susan Ramsey, PhD","PRINCIPAL_INVESTIGATOR",[34,38],{"name":31,"role":35,"phone":36,"phoneExt":11,"email":37},"CONTACT","401-444-7831","sramsey@brownhealth.org",{"name":39,"role":35,"phone":40,"phoneExt":11,"email":41},"Evan Ames","401-444-2474","evan.ames@brownhealth.org",[43],{"facility":5,"status":44,"city":45,"state":46,"zip":47,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"RECRUITING","Providence","Rhode Island","02903","United States","US",{"type":51,"coordinates":52},"Point",[53,54],-71.41283,41.82399,{"lat":54,"lon":53},[57],{"name":39,"role":35,"phone":40,"phoneExt":11,"email":41},{"type":59,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR",[61],{"name":62,"class":63},"Ksana Health","INDUSTRY","100652779","personalized-addiction-treatment-ehancement-100652779",false,"NCT07778394","Personalized Addiction Treatment eHancement","The Vira Platform: A Contextually Triggered Just-in-Time Adaptive Intervention for Opioid Use Disorder","Project Path","Inclusion Criteria:\n\n* Age 22+\n* Current Opioid Use Disorder diagnosis\n* Prescribed buprenorphine or methadone\n* Initiated or reinitiated buprenorphine or methadone treatment recently\n* Access to personal smartphone\n\nExclusion Criteria:\n\n* Not fluent in English\n* Limited mental capacity or inability to provided informed consent","ALL","22 Years",{"count":75,"type":76},40,"ESTIMATED","INTERVENTIONAL",[79],"NA","Many patients stop medication-based treatments for Opioid Use Disorder (OUD) prematurely, placing them at increased risk for overdose and death. Providing targeted interventions for OUD, particularly through an accessible, digital health platform, is a potential way to enhance recovery and keep patients engaged in care. The current study seeks to test whether a digital mental health platform, delivered by peer recovery support specialists to individuals prescribed buprenorphine or methadone medication, will improve treatment outcomes for this high risk population.",[82,83,84],"Opioid Use Disorder","mHealth","Peer Support",[86,87],"Peer Recovery Support","Digital Support","2026-08-18",{"date":90,"type":91},"2026-08-21","ACTUAL",{"date":93,"type":91},"2026-08-13",{"date":95,"type":76},"2027-03-31",{"name":5,"class":6},1]